Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
AUPH
MLYS
Add up to 3 more stocks
AUPH
Aurinia Pharmaceuticals Inc.
+0.19%
$15.75+0.03Delayed quote: Oct 6, 2026, 2:15 PM EDT
Market Cap
$2.03B
52W Range
$10.90 - $19.25
MLYS
Mineralys Therapeutics, Inc.
-4.44%
$22.26-1.04Delayed quote: Oct 6, 2026, 2:10 PM EDT
Market Cap
$1.96B
52W Range
$22.30 - $47.65
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 6.88 | N/A |
| Forward P/E | 16.68 | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 3.29 | 3.56 |
| P/S Ratio | 6.50 | N/A |
| P/FCF Ratio | 11.67 | N/A |
| EV/EBITDA | 11.20 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 90.4% | 0.0% |
| Operating Margin | 37.1% | 0.0% |
| Net Margin | 100.8% | 0.0% |
| ROE | 51.1% | -63.5% |
| ROA | 39.6% | -52.3% |
| ROIC | 21.8% | -57.2% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 5.42 | 34.46 |
| Quick Ratio | 4.97 | 34.46 |
| Debt/Equity | 0.10 | 0.18 |
| Interest Coverage | 24.23 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.